Frédéric Allemand
Directeur Général chez Emosis SAS
Profil
Frédéric Allemand is the founder and the Chief Executive Officer of Emosis SAS, a company founded in 2015.
He is currently the Director of Business Development at Biocortech SAS.
Dr. Allemand has also held positions as Director of Business Development at Rhenovia Pharma SAS, Principal at Bayer Pharmaceuticals Corp., Principal at Hybrigenics SA, Principal at Biovector Therapeutics SA, Principal at promed GmbH, and Principal at Syngenta Biotechnology, Inc.
Postes actifs de Frédéric Allemand
| Sociétés | Poste | Début |
|---|---|---|
Biocortech SAS
 Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Emosis SAS
 Emosis SAS Miscellaneous Commercial ServicesCommercial Services Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France. | Directeur Général | 01/01/2015 |
Anciens postes connus de Frédéric Allemand
| Sociétés | Poste | Fin |
|---|---|---|
Rhenovia Pharma SAS
 Rhenovia Pharma SAS Miscellaneous Commercial ServicesCommercial Services Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France. | Corporate Officer/Principal | - |
Syngenta Biotechnology, Inc.
 Syngenta Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Syngenta Biotechnology, Inc. provides genetics research and development services and is ultimately controlled by the Government of China. The company is based in Research Triangle Park, NC. | Corporate Officer/Principal | - |
promed GmbH
 promed GmbH Medical DistributorsDistribution Services Part of Xiamen Comfort Science & Technology Group Co., Ltd., promed GmbH sells medical equipment for nail and skin care. The company is based in Farchant, Germany. The CEO of the German company is Andreas Schuster. promed was acquired by Medisana GmbH, part of Xiamen Comfort Science & Technology Group Co., Ltd. from October 27, 2016 on August 30, 2005 for $0.71 million. | Corporate Officer/Principal | - |
| ATON | Corporate Officer/Principal | - |
Biovector Therapeutics SA
 Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATON | Health Technology |
| Entreprise privées | 7 |
|---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Health Technology |
| Bayer Pharmaceuticals Corp. | |
Biovector Therapeutics SA
Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France. | Health Technology |
promed GmbH
promed GmbH Medical DistributorsDistribution Services Part of Xiamen Comfort Science & Technology Group Co., Ltd., promed GmbH sells medical equipment for nail and skin care. The company is based in Farchant, Germany. The CEO of the German company is Andreas Schuster. promed was acquired by Medisana GmbH, part of Xiamen Comfort Science & Technology Group Co., Ltd. from October 27, 2016 on August 30, 2005 for $0.71 million. | Distribution Services |
Syngenta Biotechnology, Inc.
Syngenta Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Syngenta Biotechnology, Inc. provides genetics research and development services and is ultimately controlled by the Government of China. The company is based in Research Triangle Park, NC. | Commercial Services |
Rhenovia Pharma SAS
Rhenovia Pharma SAS Miscellaneous Commercial ServicesCommercial Services Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France. | Commercial Services |
Emosis SAS
Emosis SAS Miscellaneous Commercial ServicesCommercial Services Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France. | Commercial Services |
